DJIA 16,493.37 -69.93 -0.42%
NASDAQ 4,352.64 -17.13 -0.39%
S&P 500 1,925.15 -5.52 -0.29%
market minute promo

company name or ticker

Spectrum Pharmaceuticals Submits NDA for Belinostat to FDA

Spectrum Pharmaceuticals Stock Sees Short Interest Drop 11%

SPPI Loss Narrower than Ests, Fusilev Grows - Analyst Blog

Spectrum Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript

Spectrum Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast)

SPPI Crosses Above Key Moving Average Level

Is Pessimism Warranted for These 3 Most Hated Biotech Stocks?

Short-sellers have dog-piled into these three biotech companies. Is their pessimism warranted or have emotions gotten the better of investors?

UPDATE: H.C. Wainwright Initiates Coverage on Spectrum Pharmaceuticals on EPS Valuation Methodology

Benzinga's Top Initiations

Could New Competition Create the Next Wave of Stock Losses for This Biotech?

Many think Amarin's initial struggles with Vascepa are normal, and that all bad news is priced into the stock. But with new competition rising, investors might want to buckle up for a Spectrum-like ride.
See More Articles...